APA (7th ed.) Citation

Emoto‐Yamamoto, Y., Iida, S., Kawanishi, T., & Fukuoka, M. (2015). Population pharmacokinetics of erlotinib in Japanese patients with advanced non-small cell lung cancer. Journal of Clinical Pharmacy & Therapeutics, 40(2), 232. https://doi.org/10.1111/jcpt.12232

Chicago Style (17th ed.) Citation

Emoto‐Yamamoto, Y., S. Iida, T. Kawanishi, and M. Fukuoka. "Population Pharmacokinetics of Erlotinib in Japanese Patients with Advanced Non-small Cell Lung Cancer." Journal of Clinical Pharmacy & Therapeutics 40, no. 2 (2015): 232. https://doi.org/10.1111/jcpt.12232.

MLA (9th ed.) Citation

Emoto‐Yamamoto, Y., et al. "Population Pharmacokinetics of Erlotinib in Japanese Patients with Advanced Non-small Cell Lung Cancer." Journal of Clinical Pharmacy & Therapeutics, vol. 40, no. 2, 2015, p. 232, https://doi.org/10.1111/jcpt.12232.